DNAJB4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.752000E-01
Normal-vs-Stage2
6.383400E-01
Normal-vs-Stage3
3.909600E-02
Normal-vs-Stage4
7.586200E-01
Stage1-vs-Stage2
8.469600E-01
Stage1-vs-Stage3
4.746000E-01
Stage1-vs-Stage4
2.453800E-01
Stage2-vs-Stage3
2.269600E-02
Stage2-vs-Stage4
4.166600E-01
Stage3-vs-Stage4
1.326030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.089800E-01
Normal-vs-AfricanAmerican
5.737000E-01
Normal-vs-Asian
3.370000E-02
Caucasian-vs-AfricanAmerican
9.633600E-01
Caucasian-vs-Asian
4.544500E-02
AfricanAmerican-vs-Asian
2.601600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.232800E-01
Normal-vs-Female
2.358000E-01
Male-vs-Female
3.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.484400E-01
Normal-vs-Age(41-60Yrs)
9.910600E-01
Normal-vs-Age(61-80Yrs)
2.622600E-01
Normal-vs-Age(81-100Yrs)
2.095700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.992200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.409800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.141800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.366300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.944800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.065970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.324780E-01
Normal-vs-Daily Drinker
1.074220E-02
Normal-vs-Weekly Drinker
4.482600E-01
Normal-vs-Occasional Drinker
8.362000E-01
Normal-vs-Social Drinker
6.054400E-01
Non Drinker-vs-Daily Drinker
2.976000E-01
Non Drinker-vs-Weekly Drinker
4.852400E-01
Non Drinker-vs-Occasional Drinker
3.949800E-01
Non Drinker-vs-Social Drinker
2.551000E-01
Daily Drinker-vs-Weekly Drinker
2.106400E-01
Daily Drinker-vs-Occasional Drinker
2.166400E-01
Daily Drinker-vs-Social Drinker
1.114640E-01
Weekly Drinker-vs-Occasional Drinker
6.703400E-01
Weekly Drinker-vs-Social Drinker
7.463600E-01
Occasional Drinker-vs-Social Drinker
8.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.117200E-01
Normal-vs-Grade 2
4.552400E-01
Normal-vs-Grade 3
3.759600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.689500E-02
Grade 1-vs-Grade 3
7.452600E-01
Grade 1-vs-Grade 4
5.117200E-01
Grade 2-vs-Grade 3
7.882200E-02
Grade 2-vs-Grade 4
4.552400E-01
Grade 3-vs-Grade 4
3.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.281000E-01
Normal-vs-NonDiabetic
5.763200E-01
Diabetic-vs-NonDiabetic
8.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.652800E-01
Normal-vs-NoPancreatitis
5.952400E-01
Pancreatitis-vs-NoPancreatitis
8.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.445200E-01
Normal-vs-N1
6.910600E-01
N0-vs-N1
1.576370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.689000E-01
Normal-vs-TP53-NonMutant
2.022600E-01
TP53-Mutant-vs-TP53-NonMutant
6.950800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
